WHO approves Moderna Covid vaccine for emergency use

WHO approves Moderna Covid vaccine for emergency use

PanARMENIAN.Net - The World Health Organization (WHO) on Friday, April 30 listed the Moderna coronavirus vaccine for emergency use, adding another shot to its arsenal in the fight against the coronavirus, The Hill reports.

The shot from Moderna, which is estimated to have an efficacy rate of 94.1%, joins shots from Pfizer-BioNTech, AstraZeneca-SK Bio, Serum Institute of India and Janssen on WHO’s list of emergency use vaccines.

The addition of Moderna’s shot to the WHO’s emergency use listing is a prerequisite for it to be a part of COVAX, the program to disseminate shots to low-income countries. It also allows countries to expedite their own regulatory approval to import and administer the Covid-19 vaccine.

The U.S. granted emergency use authorization to the Moderna shot in December, with the European Union following shortly after in January.

The authorization comes as the world works to ramp up its coronavirus vaccinations to significantly curb the pandemic over a year after it broke out in Wuhan, China.

 Top stories
The Prosecutor’s Office has released surveillance footage and said that one of the detainees in the case, Iveri Melashvili.
Destinations welcomed 900m fewer international tourists in January–October when compared with the same period of 2019.
Austrian authorities said at least one gunman remained on the run at 1am Vienna time on November 3.
Moderna’s proposed price would apply to the United States and other high-income countries.
Partner news